Cleopatra Hospital Company (CLHO)
Egyptian Exchange · Egypt · prices in EGP · close of 22 Oct 2026
Key indicators
| Last close | EGP 13.50 |
|---|---|
| 52-week range | 11.00 – 19.72 |
| Return, 1 month / 3 months | −14.7% / −20.1% |
| Return, 1 year / 3 years | +5.5% / +206.8% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -26.3% |
| Average daily value traded | 56.08M EGP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cleopatra Hospital Company runs a network of private hospitals in Egypt, centred on its hospital in Heliopolis in Cairo and extending to other facilities in the country. It provides inpatient and outpatient medical care, including surgery, diagnostic services, intensive care and specialist treatment, to patients who pay for private healthcare and to corporate and insurance clients. The company is based in Cairo and serves patients across Egypt through its hospital network.
On this site Cleopatra Hospital Company appears as a stock on the Egyptian Exchange (Egypt), code CLHO, with prices in Egyptian pounds (EGP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cleopatra Hospital Company (CLHO) trades on the Egyptian Exchange in Egypt. It last closed at EGP 13.50 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 113 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.5% and over the last three months it fell 20.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.0% | ||
| From 52-week high | -26.3% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.1% | ||
| 6-month return | 3.4% | ||
| 12-month return, skipping the last month | 23.7% | ||
| Stability (higher is calmer) | 71 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.3% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 56.08M EGP | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −3.8% |
|---|---|
| 1 month | −14.7% |
| 3 months | −20.1% |
| 6 months | +3.4% |
| 1 year | +5.5% |
| 3 years | +206.8% |
| 5 years | +214.7% |
Signals
| 50-day / 200-day average | 16.09 / 14.67 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.59 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.